Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Consulting agrmnt Inv. presentation
|
Eloxx Pharmaceuticals, Inc. (ELOX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
03/12/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
03/06/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
03/14/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
03/16/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
10/13/2017 |
10-K
| Annual Report for the period ended June 30, 2017 |
10/13/2016 |
10-K
| Annual Report for the period ended June 30, 2016 |
10/09/2015 |
10-K
| Annual Report for the period ended June 30, 2015 |
09/29/2014 |
10-K
| Annual Report for the period ended June 30, 2014 |
09/11/2013 |
10-K
| Annual Report for the period ended June 30, 2013 |
09/28/2012 |
10-K
| Annual Report for the period ended June 30, 2012 |
09/28/2011 |
10-K
| Annual Report for the period ended June 30, 2011 |
09/28/2010 |
10-K
| Annual Report for the period ended June 30, 2010 |
09/28/2009 |
10-K
| Annual Report for the period ended June 30, 2009 |
09/26/2008 |
10-K
| Annual Report for the period ended June 30, 2008 |
09/28/2007 |
10-K
| Annual Report for the period ended June 30, 2007 |
10/13/2006 |
10-K
| Annual Report for the period ended June 30, 2006 |
|
|